Variant report

Variant	nsv960931
Chromosome Location	chr19:45073821-45102725
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1305)
CpG islands
(count:0)
Chromatin interactive
region (count:45)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:1305 , 50 per page) page: 1 2 3 4 5 6 7 ... 27

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr19:45095854-45096181	K562	blood:	n/a	n/a
2	ARID3A	chr19:45094060-45094061	K562	blood:	n/a	n/a
3	ARID3A	chr19:45091138-45092150	K562	blood:	n/a	n/a
4	ARID3A	chr19:45080413-45080442	K562	blood:	n/a	n/a
5	ARID3A	chr19:45086315-45086391	K562	blood:	n/a	n/a
6	ARID3A	chr19:45091616-45092099	HepG2	liver:	n/a	n/a
7	ARID3A	chr19:45074625-45074997	HepG2	liver:	n/a	n/a
8	ARID3A	chr19:45076650-45077105	K562	blood:	n/a	n/a
9	ATF1	chr19:45076999-45077191	K562	blood:	n/a	n/a
10	ATF1	chr19:45095719-45096287	K562	blood:	n/a	n/a
11	ATF1	chr19:45091114-45092118	K562	blood:	n/a	n/a
12	ATF3	chr19:45091003-45092133	K562	blood:	n/a	n/a
13	BACH1	chr19:45086274-45086461	K562	blood:	n/a	n/a
14	BCL3	chr19:45091275-45092579	A549	lung:	n/a	n/a
15	BCL3	chr19:45098360-45098642	GM12878	blood:	n/a	n/a
16	BCL3	chr19:45091578-45092509	A549	lung:	n/a	n/a
17	BHLHE40	chr19:45095704-45096096	K562	blood:	n/a	n/a
18	BHLHE40	chr19:45091749-45091925	K562	blood:	n/a	n/a
19	BHLHE40	chr19:45095693-45095964	A549	lung:	n/a	n/a
20	BRCA1	chr19:45091323-45092459	Hela-S3	cervix:	n/a	n/a
21	CBX3	chr19:45094924-45095315	K562	blood:	n/a	n/a
22	CCNT2	chr19:45093783-45094242	K562	blood:	n/a	n/a
23	CCNT2	chr19:45095665-45095958	K562	blood:	n/a	n/a
24	CCNT2	chr19:45091907-45092199	K562	blood:	n/a	n/a
25	CCNT2	chr19:45077034-45077178	K562	blood:	n/a	n/a
26	CEBPB	chr19:45074580-45074973	HepG2	liver:	n/a	n/a
27	CEBPB	chr19:45091294-45092589	A549	lung:	n/a	chr19:45091829-45091840
28	CEBPB	chr19:45095723-45095855	HepG2	liver:	n/a	chr19:45095753-45095764
29	CEBPB	chr19:45080160-45080176	IMR90	lung:	n/a	n/a
30	CEBPB	chr19:45091661-45092046	ECC-1	luminal epithelium:	n/a	chr19:45091829-45091840
31	CEBPB	chr19:45091349-45092595	HCT-116	colon:	n/a	chr19:45091829-45091840
32	CEBPB	chr19:45091680-45092071	MCF-7	breast:	n/a	chr19:45091829-45091840
33	CEBPB	chr19:45093892-45094229	K562	blood:	n/a	n/a
34	CEBPB	chr19:45074645-45075031	HepG2	liver:	n/a	n/a
35	CEBPB	chr19:45091197-45092044	K562	blood:	n/a	chr19:45091829-45091840
36	CEBPB	chr19:45088981-45089169	A549	lung:	n/a	n/a
37	CEBPB	chr19:45091654-45092051	K562	blood:	n/a	chr19:45091829-45091840
38	CEBPB	chr19:45095623-45095913	A549	lung:	n/a	chr19:45095753-45095764
39	CEBPB	chr19:45080093-45080317	K562	blood:	n/a	n/a
40	CEBPB	chr19:45075540-45075712	HepG2	liver:	n/a	n/a
41	CEBPB	chr19:45074691-45074929	HepG2	liver:	n/a	n/a
42	CEBPB	chr19:45091471-45092421	A549	lung:	n/a	chr19:45091829-45091840
43	CEBPB	chr19:45091428-45092109	A549	lung:	n/a	chr19:45091829-45091840
44	CEBPB	chr19:45074641-45075024	HepG2	liver:	n/a	n/a
45	CEBPB	chr19:45075588-45075788	HepG2	liver:	n/a	n/a
46	CEBPB	chr19:45095686-45095883	K562	blood:	n/a	chr19:45095753-45095764
47	CEBPB	chr19:45091131-45092094	K562	blood:	n/a	chr19:45091829-45091840
48	CEBPB	chr19:45091678-45092013	HepG2	liver:	n/a	chr19:45091829-45091840
49	CEBPB	chr19:45091198-45092140	IMR90	lung:	n/a	chr19:45091829-45091840
50	CEBPB	chr19:45080107-45080290	A549	lung:	n/a	n/a

No data

(count:45 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:45074128..45076823-chr19:45084175..45086201,2	MCF-7	breast:
2	chr19:45091239..45092125-chr19:45160341..45161067,2	MCF-7	breast:
3	chr19:45071449..45074096-chr19:45078415..45080895,2	K562	blood:
4	chr19:45016284..45016826-chr19:45073849..45074372,2	MCF-7	breast:
5	chr19:45083158..45085994-chr19:45086371..45089240,3	K562	blood:
6	chr19:45004225..45006236-chr19:45098622..45100400,2	K562	blood:
7	chr19:45094156..45097304-chr19:45097704..45100336,3	K562	blood:
8	chr19:45083158..45085994-chr19:45086371..45089240,3	K562	blood:
9	chr19:45102219..45104144-chr19:45145865..45148557,2	MCF-7	breast:
10	chr19:45090347..45092952-chr19:45163399..45165875,2	MCF-7	breast:
11	chr19:45074225..45075084-chr19:45160196..45161185,6	K562	blood:
12	chr19:45075438..45078386-chr19:45082618..45085049,2	K562	blood:
13	chr19:45094156..45097304-chr19:45097704..45100336,3	K562	blood:
14	chr19:45091277..45092240-chr19:45157832..45158354,2	MCF-7	breast:
15	chr19:45080329..45080832-chr3:69448587..69449087,2	MCF-7	breast:
16	chr19:45075352..45076164-chr19:45160264..45161096,2	MCF-7	breast:
17	chr19:45016245..45017042-chr19:45088857..45089751,3	MCF-7	breast:
18	chr19:45080143..45081410-chr19:45160340..45161160,3	MCF-7	breast:
19	chr19:45077994..45080248-chr19:45087095..45089133,2	MCF-7	breast:
20	chr19:45078734..45080955-chr19:45088424..45090075,2	K562	blood:
21	chr19:45098508..45100493-chr19:45105050..45107406,3	K562	blood:
22	chr19:45090855..45093405-chr19:45093462..45095676,2	MCF-7	breast:
23	chr19:45078352..45082939-chr19:45083860..45086138,4	K562	blood:
24	chr19:45090855..45093405-chr19:45093462..45095676,2	MCF-7	breast:
25	chr19:45089492..45092172-chr19:45146831..45148815,2	MCF-7	breast:
26	chr19:45073687..45076293-chr19:45087873..45090777,2	MCF-7	breast:
27	chr19:45078734..45080955-chr19:45088424..45090075,2	K562	blood:
28	chr19:45073833..45074821-chr19:45348052..45348614,3	K562	blood:
29	chr19:45078352..45082939-chr19:45083860..45086138,4	K562	blood:
30	chr19:45079862..45080434-chr19:45088704..45089652,2	MCF-7	breast:
31	chr19:45077994..45080248-chr19:45087095..45089133,2	MCF-7	breast:
32	chr1:149223695..149224384-chr19:45095146..45095646,2	NB4	blood:
33	chr19:45042789..45045483-chr19:45076508..45078794,2	K562	blood:
34	chr19:45075438..45078386-chr19:45082618..45085049,2	K562	blood:
35	chr19:45079916..45080870-chr19:45494069..45494981,2	MCF-7	breast:
36	chr19:45079963..45080740-chr19:45157832..45158338,2	MCF-7	breast:
37	chr19:45078450..45080278-chr19:45082869..45085478,2	MCF-7	breast:
38	chr19:45091258..45091782-chr19:45160836..45161506,2	MCF-7	breast:
39	chr19:45080209..45080840-chr19:45157826..45158351,2	MCF-7	breast:
40	chr19:45080328..45080888-chr19:45160207..45160721,2	K562	blood:
41	chr19:45079862..45080434-chr19:45088704..45089652,2	MCF-7	breast:
42	chr19:45078450..45080278-chr19:45082869..45085478,2	MCF-7	breast:
43	chr19:45074128..45076823-chr19:45084175..45086201,2	MCF-7	breast:
44	chr19:45074025..45075864-chr19:45246101..45248322,2	MCF-7	breast:
45	chr19:45090304..45092038-chr19:45111542..45114028,2	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000224366	TF binding region
ENSG00000186567	chromatin interactions
ENSG00000167384	chromatin interactions
ENSG00000224366	chromatin interactions
ENSG00000073008	chromatin interactions
ENSG00000206737	chromatin interactions

Extended variants
information (count: 1238 )
Associated
traits (count: 66 )

Variant overlapped rSNPs/rCNVs (count:1238 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs571255202	chr19:45073826-45073827	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs151283398	chr19:45073840-45073841	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs184023587	chr19:45073936-45073937	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs555260516	chr19:45073954-45073955	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs567221618	chr19:45073974-45073975	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs73561992	chr19:45073992-45073993	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs574145157	chr19:45074016-45074017	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs573431082	chr19:45074041-45074042	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs555843163	chr19:45074053-45074054	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs140540281	chr19:45074101-45074102	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs188905219	chr19:45074105-45074106	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs117868370	chr19:45074126-45074127	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs73561994	chr19:45074149-45074150	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs150028856	chr19:45074173-45074174	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs61250595	chr19:45074176-45074177	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs846848	chr19:45074177-45074178	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs530095836	chr19:45074191-45074192	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs181713011	chr19:45074192-45074193	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs185463219	chr19:45074199-45074200	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs3059878	chr19:45074212-45074213	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs386389083	chr19:45074215-45074216	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs532369127	chr19:45074223-45074224	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs145356836	chr19:45074236-45074237	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs571173616	chr19:45074243-45074244	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs142590137	chr19:45074251-45074252	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs547227993	chr19:45074268-45074269	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs567460882	chr19:45074280-45074281	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs536095975	chr19:45074298-45074299	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs556218357	chr19:45074303-45074304	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs557359882	chr19:45074372-45074373	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs201683446	chr19:45074389-45074390	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs115761065	chr19:45074395-45074396	Weak transcription Active TSS Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs111593825	chr19:45074401-45074402	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs544718165	chr19:45074485-45074486	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs558603712	chr19:45074517-45074518	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs137897810	chr19:45074540-45074541	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs190769958	chr19:45074565-45074566	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs574968396	chr19:45074639-45074640	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs182184221	chr19:45074643-45074644	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs141991815	chr19:45074654-45074655	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs74172479	chr19:45074764-45074765	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs545762512	chr19:45074837-45074838	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs559324285	chr19:45074851-45074852	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs527541176	chr19:45074913-45074914	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs185961147	chr19:45074919-45074920	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs189848648	chr19:45074930-45074931	Weak transcription Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs529875159	chr19:45075035-45075036	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs181110290	chr19:45075073-45075074	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs569735334	chr19:45075082-45075083	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs561255980	chr19:45075094-45075095	Weak transcription Enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:66)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Cancer	20164920	CNVD
Multiple myeloma	16616336	CNVD
Ovarian cancer	20800559	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Spondylocostal dysostosis	21085971	CNVD
Nicotine metabolism	21956041	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	20459617	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:391 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:45070000-45074400	Weak transcription	Fetal Adrenal Gland	Adrenal Gland
2	chr19:45070400-45080400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
3	chr19:45070600-45075200	Weak transcription	Primary monocytes fromperipheralblood	blood
4	chr19:45073600-45074200	Enhancers	HepG2	liver
5	chr19:45073800-45076400	Enhancers	K562	blood
6	chr19:45074200-45074400	Active TSS	Liver	Liver
7	chr19:45074200-45075600	Enhancers	A549	lung
8	chr19:45074200-45076000	Flanking Active TSS	HepG2	liver
9	chr19:45074400-45074800	Flanking Active TSS	Liver	Liver
10	chr19:45074400-45074800	Flanking Active TSS	Fetal Intestine Small	intestine
11	chr19:45074400-45075000	Bivalent Enhancer	Stomach Mucosa	stomach
12	chr19:45074400-45075200	Flanking Active TSS	Duodenum Mucosa	Duodenum
13	chr19:45074400-45075600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
14	chr19:45074400-45075600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
15	chr19:45074400-45077800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
16	chr19:45074400-45078200	Enhancers	Fetal Intestine Large	intestine
17	chr19:45074600-45075000	Enhancers	Fetal Kidney	kidney
18	chr19:45074800-45075000	Enhancers	Rectal Mucosa Donor 29	rectum
19	chr19:45074800-45076200	Enhancers	Liver	Liver
20	chr19:45074800-45076200	Enhancers	Monocytes-CD14+_RO01746	blood
21	chr19:45074800-45077800	Enhancers	Fetal Intestine Small	intestine
22	chr19:45075000-45075600	Enhancers	Lung	lung
23	chr19:45075000-45076200	Weak transcription	Fetal Kidney	kidney
24	chr19:45075200-45076400	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr19:45075200-45076400	Enhancers	Duodenum Mucosa	Duodenum
26	chr19:45075600-45080400	Weak transcription	A549	lung
27	chr19:45075800-45076000	Enhancers	Fetal Lung	lung
28	chr19:45076000-45076600	Enhancers	HepG2	liver
29	chr19:45076200-45078200	Enhancers	Fetal Kidney	kidney
30	chr19:45076400-45077200	Flanking Active TSS	K562	blood
31	chr19:45076600-45077800	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
32	chr19:45076600-45080400	Weak transcription	HepG2	liver
33	chr19:45076800-45077000	Enhancers	Fetal Lung	lung
34	chr19:45076800-45077600	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
35	chr19:45077200-45077600	Enhancers	K562	blood
36	chr19:45077200-45079000	Enhancers	HUES6 Cell Line	embryonic stem cell
37	chr19:45077600-45077800	Flanking Active TSS	K562	blood
38	chr19:45077600-45078200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
39	chr19:45077800-45078800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
40	chr19:45077800-45079000	Enhancers	K562	blood
41	chr19:45078200-45078400	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
42	chr19:45078200-45078600	Weak transcription	Fetal Kidney	kidney
43	chr19:45078200-45083600	Weak transcription	Fetal Intestine Large	intestine
44	chr19:45078600-45079000	Enhancers	Fetal Kidney	kidney
45	chr19:45078800-45079000	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
46	chr19:45079000-45080600	Weak transcription	HUES6 Cell Line	embryonic stem cell
47	chr19:45079000-45084400	Weak transcription	K562	blood
48	chr19:45080400-45080800	Enhancers	ES-I3 Cell Line	embryonic stem cell
49	chr19:45080400-45080800	Enhancers	A549	lung
50	chr19:45080400-45080800	Enhancers	HepG2	liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links